v3.25.1
Condensed Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Income Statement [Abstract]    
Revenues:
Expenses:    
Research and development 236,058 260,359
General and administrative 438,493 514,458
Total expenses 674,551 774,817
Loss from operations (674,551) (774,817)
Other income:    
Interest income 41,705 90,106
Net loss $ (632,846) $ (684,711)
Basic net loss per share $ (0.00) $ (0.00)
Diluted net loss per share $ (0.00) $ (0.00)
Weighted average common stock shares outstanding - basic 172,323,545 172,079,589
Weighted average common stock shares outstanding - diluted 172,323,545 172,079,589

Source